PM
VMD icon

Penbrook Management’s Viemed Healthcare VMD Stock Holding History

Penbrook Management’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Buy
277,178
+4,780
+2% +$47.3K 2.02% 9
2026
Q1 		$2.51M Buy
272,398
+850
+0.3% +$7.07K 1.9% 13
2025
Q4 		$2.02M Sell
271,548
-780
-0.3% -$5.34K 1.39% 15
2025
Q3 		$1.85M Buy
272,328
+92,308
+51% +$625K 1.29% 15
2025
Q2 		$1.24M Sell
180,020
-26,557
-13% -$180K 0.94% 26
2025
Q1 		$1.5M Sell
206,577
-7,280
-3% -$57.2K 1.14% 20
2024
Q4 		$1.72M Hold
213,857
– – 1.17% 17
2024
Q3 		$1.57M Sell
213,857
-17,750
-8% -$127K 1.02% 20
2024
Q2 		$1.52M Buy
231,607
+162,670
+236% +$1.23M 0.93% 21
2024
Q1 		$650K Sell
68,937
-850
-1% -$7.29K 0.4% 54
2023
Q4 		$548K Sell
69,787
-450
-0.6% -$3.27K 0.37% 62
2023
Q3 		$473K Buy
70,237
+19,387
+38% +$159K 0.35% 66
2023
Q2 		$497K Hold
50,850
– – 0.36% 64
2023
Q1 		$491K Buy
+50,850
New +$443K 0.38% 63

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Penbrook Management's VMD Position: Q2 2026 in Review

Penbrook Management increased its Viemed Healthcare (VMD) stake by 1.8% in Q2 2026, buying an estimated $47.3K and bringing the position to 277,178 shares worth $3.16M. The position accounts for 2.02% of the portfolio, ranked #9.

Penbrook Management first reported a position in VMD in Q1 2023 and has held it in 14 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Penbrook Management held 277,178 shares of Viemed Healthcare worth $3.16M as of Q2 2026.
  • Penbrook Management bought 4,780 Viemed Healthcare shares in Q2 2026, an estimated $47.3K.
  • Viemed Healthcare made up 2.02% of Penbrook Management's portfolio in Q2 2026, its #9 holding.
  • Penbrook Management first reported a position in Viemed Healthcare in Q1 2023 and has held it in 14 quarters since.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.